To read more on this topic click here.
Can a digital pen “revolutionise” Parkinson’s diagnosis?
News
Author: Sophie BatesPublished: 23 January 2020
Prep: Cook: Serves:
A Parkinson’s diagnosing pen has sealed a five-year manufacturing deal from stationery brand Stabilo.
The Neuromotor Pen– developed by Scottish medical devices company Manus Neurodynamica – analyses a user’s hand and limb movements as they perform a number of drawing tests on a tablet.
Microchips within the device record the data of even the smallest of movements, and determine whether a user has Parkinson’s in a simple and non-invasive way.
Researchers believe the pen could be adapted in the future for use in monitoring patients with Alzheimer’s, multiple sclerosis and those that have suffered from a stroke.
Peter Kämpf, director of research and development at Schwan-Stabilo, said: “This novel product can potentially revolutionise the diagnosis and treatment of neuromotor diseases, and we are excited to be involved in its development and in helping bring it to market.”
For more information on Parkinson’s and assessment tools please visit the Parkinson’s Europe website.
Read more:
Scotland sees soaring Parkinson’s rate
Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds
Last Month
Next Month
Share this story
Related articles
Special reports
Ask the expert: Is Parkinson’s disease hereditary?
Dr Patrick Lewis discusses the role of genetics
READ MOREResources & Tools
Dealing with a diagnosis: a guide to Parkinson’s
A new guidebook offers peer-to-peer advice
READ MOREHealth & Fitness
Tonya’s trainers: the long road back to running
Advice for long-distance running with Parkinson’s
READ MORE
Comments